Background Long-term effects of Coronavirus Disease 2019 (COVID-19) are increasingly recognized as having a significant impact on Health-Related Quality of Life (HRQoL). Understanding HRQoL status for each patient affected by long COVID-19 and its determinants may have a key role to prevent and treat this condition.Methods In this prospective observational study conducted in a large academic COVID-19 hospital in Rome, participants were contacted 2 years after hospital admission for severe COVID-19. To assess HRQoL, EQ-5D-5L and Visual analog scale (EQ VAS) standard questionnaires were administered by interview. Logistic regression model was used to the five health dimensions as dependent variables (0 = no problem, 1 = some/extreme problem).Key results In 137 enrolled patients, the mean pre-COVID and post-COVID EQ-5D-5L index and EQ-VAS score were 0.97 (SD 0.06), 0.79 (SD 0.26) and 72.38 (SD 15.18), respectively. After subdivision of the participants for clinical and social variables, the EQ-5D-5L index resulted significantly lower than in the pre-COVID-19 period. Female gender, unemployed status, and chronic comorbidities were the most common predictors for having any problems in each EQ-5D-5L domain, while also older age and higher Body Mass Index (BMI) showed to be related to a lower EQ-VAS score.Conclusion HRQoL showed to be still low in patients 2 years after acute severe COVID-19. Given the significant impact of SARS-CoV-2 on long-term chronic symptoms, predictors of poor outcomes must be considered during the acute phase of illness to plan a tailored follow-up path for each patient.

Health-related quality of life in survivors of severe covid-19 infection / D'Ettorre, Gabriele; Vassalini, Paolo; Coppolelli, Vincenzo; Gentilini Cacciola, Elio; Sanitinelli, Letizia; Maddaloni, Luca; Fabris, Silvia; Mastroianni, Claudio M; D'Ettorre, Gabriella; Ceccarelli, Giancarlo. - In: PHARMACOLOGICAL REPORTS. - ISSN 1734-1140. - 74:6(2022), pp. 1286-1295. [10.1007/s43440-022-00433-5]

Health-related quality of life in survivors of severe covid-19 infection

Vassalini, Paolo;Coppolelli, Vincenzo;Maddaloni, Luca;Fabris, Silvia;Mastroianni, Claudio M;d'Ettorre, Gabriella;Ceccarelli, Giancarlo
2022

Abstract

Background Long-term effects of Coronavirus Disease 2019 (COVID-19) are increasingly recognized as having a significant impact on Health-Related Quality of Life (HRQoL). Understanding HRQoL status for each patient affected by long COVID-19 and its determinants may have a key role to prevent and treat this condition.Methods In this prospective observational study conducted in a large academic COVID-19 hospital in Rome, participants were contacted 2 years after hospital admission for severe COVID-19. To assess HRQoL, EQ-5D-5L and Visual analog scale (EQ VAS) standard questionnaires were administered by interview. Logistic regression model was used to the five health dimensions as dependent variables (0 = no problem, 1 = some/extreme problem).Key results In 137 enrolled patients, the mean pre-COVID and post-COVID EQ-5D-5L index and EQ-VAS score were 0.97 (SD 0.06), 0.79 (SD 0.26) and 72.38 (SD 15.18), respectively. After subdivision of the participants for clinical and social variables, the EQ-5D-5L index resulted significantly lower than in the pre-COVID-19 period. Female gender, unemployed status, and chronic comorbidities were the most common predictors for having any problems in each EQ-5D-5L domain, while also older age and higher Body Mass Index (BMI) showed to be related to a lower EQ-VAS score.Conclusion HRQoL showed to be still low in patients 2 years after acute severe COVID-19. Given the significant impact of SARS-CoV-2 on long-term chronic symptoms, predictors of poor outcomes must be considered during the acute phase of illness to plan a tailored follow-up path for each patient.
2022
covid-19; hrool; health-related quality of life; post-covid; quality of life; sars-cov2
01 Pubblicazione su rivista::01a Articolo in rivista
Health-related quality of life in survivors of severe covid-19 infection / D'Ettorre, Gabriele; Vassalini, Paolo; Coppolelli, Vincenzo; Gentilini Cacciola, Elio; Sanitinelli, Letizia; Maddaloni, Luca; Fabris, Silvia; Mastroianni, Claudio M; D'Ettorre, Gabriella; Ceccarelli, Giancarlo. - In: PHARMACOLOGICAL REPORTS. - ISSN 1734-1140. - 74:6(2022), pp. 1286-1295. [10.1007/s43440-022-00433-5]
File allegati a questo prodotto
File Dimensione Formato  
D'Ettorre_Health-related_2022.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.18 MB
Formato Adobe PDF
1.18 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1672765
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 3
social impact